WallStreetZenWallStreetZen

NYSE: MANE
Veradermics Revenue

OverviewEarningsRevenue
DividendOwnership
Veradermics revenue was N/A for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MANE annual revenue was $0.0, with N/A growth year-over-year.

MANE revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when MANE announces revenue.

MANE Revenue History By Year

MANE Yearly RevenueMANE RevenueMANE ChangeMANE Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A

1 of 1

Veradermics Revenue FAQ

What was Veradermics's annual revenue growth in the past year?

As of Q1 2026, Veradermics's revenue has grown null year over year. Veradermics's revenue in the past year totaled N/A.

How much does Veradermics make in a year?

Veradermics's revenue by year for the past one years is:
  • Veradermics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

What was Veradermics's revenue in 2024?

Veradermics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Veradermics make in a day?

Based on Veradermics annual revenue for the past one years, MANE makes an average of $0.00 per day.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.